Fuji Pharma Co.,Ltd. 4554Short Interest
No institution currently reports a short position of 0.5% or more in Fuji Pharma Co.,Ltd. (4554). The last disclosure was on 2026-11-11 (Morgan Stanley MUFG Securities Co., Ltd., 0.42%).
Estimated short interest
0.00%
±0.00%
Estimated position (shares)
0
As of 2026-11-18
Holders (0.5% or more)
0 firms
57 reports
Estimated short interest is the sum of positions of 0.5% or more reported within the past year. It also excludes 8 institutions that fell below 0.5%. How estimates are calculated
Disclosure History Summary
| First disclosure | 2020-10-08 |
|---|---|
| Latest disclosure | 2026-11-11 (Morgan Stanley MUFG Securities Co., Ltd., 0.42%) |
| Reporting institutions | 8 firms (57 reports) |
| Peak estimated short interest | 1.30% (2025-02-07, 2 holders) |
Short Interest Trend Last 5 years, by institution, % of shares outstanding
Estimated short interest stacked by institution, counting only positions of 0.5% or more reported within the past year. The 5 largest current holders are colored and the rest are grouped as "Others". Hover over (or tap) a bar to see the breakdown.
- Nomura Securities Co., Ltd.
- Integrated Core Strategies (Asia) Pte. Ltd.
- Diversified Select Opportunities, LLC
- Barclays Capital Securities Ltd
- MERRILL LYNCH INTERNATIONAL
- Others
0.00%
Estimated short interest, 2026-11-18
Current Positions by Short Seller Latest report of each holder
| Last report | Short seller | Position (shares) | Ratio | Change | Status |
|---|---|---|---|---|---|
| 2024-03-05 | JPM Securities Japan Co Ltd. | Position 123,126 shares | Ratio 0.49% | ▼0.06% | Below 0.5% |
| 2024-05-16 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 123,704 shares | Ratio 0.49% | ▼0.07% | Below 0.5% |
| 2020-10-23 | Individual | Position 151,200 shares | Ratio 0.48% | ▼0.07% | Below 0.5% |
| 2025-05-13 | Barclays Capital Securities Ltd | Position 121,043 shares | Ratio 0.48% | ▼0.04% | Below 0.5% |
| 2025-02-12 | MERRILL LYNCH INTERNATIONAL | Position 121,522 shares | Ratio 0.48% | ▼0.11% | Below 0.5% |
| 2026-09-24 | Diversified Select Opportunities, LLC | Position 129,100 shares | Ratio 0.48% | ▼0.10% | Below 0.5% |
| 2026-11-11 | Morgan Stanley MUFG Securities Co., Ltd. | Position 113,250 shares | Ratio 0.42% | ▼0.08% | Below 0.5% |
| 2026-03-11 | Nomura Securities Co., Ltd. | Position 41,791 shares | Ratio 0.16% | ▼0.88% | Below 0.5% |
Disclosure History 57 in total
| Trade date | Short seller | Position (shares) | Ratio | Change | Note |
|---|---|---|---|---|---|
| 2026-11-11 | Morgan Stanley MUFG Securities Co., Ltd. | Position 113,250 shares | Ratio 0.42% | ▼0.08% | Below 0.5% |
| 2026-11-06 | Morgan Stanley MUFG Securities Co., Ltd. | Position 134,750 shares | Ratio 0.50% | ▲0.03% | — |
| 2026-11-05 | Morgan Stanley MUFG Securities Co., Ltd. | Position 126,050 shares | Ratio 0.47% | ▼0.04% | Below 0.5% |
| 2026-11-02 | Morgan Stanley MUFG Securities Co., Ltd. | Position 135,450 shares | Ratio 0.51% | ▲0.11% | — |
| 2026-09-24 | Diversified Select Opportunities, LLC | Position 129,100 shares | Ratio 0.48% | ▼0.10% | Below 0.5% |
| 2026-09-16 | Diversified Select Opportunities, LLC | Position 156,000 shares | Ratio 0.58% | ▼0.11% | — |
| 2026-09-14 | Diversified Select Opportunities, LLC | Position 184,200 shares | Ratio 0.69% | ▼0.09% | — |
| 2026-08-19 | Diversified Select Opportunities, LLC | Position 207,400 shares | Ratio 0.78% | ▼0.02% | — |
| 2026-08-18 | Diversified Select Opportunities, LLC | Position 212,900 shares | Ratio 0.80% | ▲0.10% | — |
| 2026-07-07 | Diversified Select Opportunities, LLC | Position 188,400 shares | Ratio 0.70% | ▲0.02% | — |
| 2026-06-03 | Diversified Select Opportunities, LLC | Position 181,500 shares | Ratio 0.68% | ▼0.11% | — |
| 2026-05-29 | Diversified Select Opportunities, LLC | Position 210,200 shares | Ratio 0.79% | ▼0.02% | — |
| 2026-05-21 | Diversified Select Opportunities, LLC | Position 215,300 shares | Ratio 0.81% | ▲0.09% | — |
| 2026-05-18 | Diversified Select Opportunities, LLC | Position 191,100 shares | Ratio 0.72% | ▲0.12% | — |
| 2026-05-13 | Diversified Select Opportunities, LLC | Position 160,300 shares | Ratio 0.60% | ▲0.09% | — |
| 2026-05-11 | Diversified Select Opportunities, LLC | Position 136,100 shares | Ratio 0.51% | ▲0.10% | — |
| 2026-03-11 | Nomura Securities Co., Ltd. | Position 41,791 shares | Ratio 0.16% | ▼0.88% | Below 0.5% |
| 2026-03-10 | Nomura Securities Co., Ltd. | Position 260,691 shares | Ratio 1.04% | ▲0.27% | — |
| 2026-03-09 | Nomura Securities Co., Ltd. | Position 191,891 shares | Ratio 0.77% | ▲0.28% | — |
| 2026-03-05 | Nomura Securities Co., Ltd. | Position 71,391 shares | Ratio 0.28% | ▼0.48% | Below 0.5% |
| 2026-03-04 | Nomura Securities Co., Ltd. | Position 191,191 shares | Ratio 0.76% | ▲0.16% | — |
| 2026-03-03 | Nomura Securities Co., Ltd. | Position 151,691 shares | Ratio 0.60% | ▲0.24% | — |
| 2026-02-27 | Nomura Securities Co., Ltd. | Position 41,091 shares | Ratio 0.16% | ▼0.55% | Below 0.5% |
| 2026-02-26 | Nomura Securities Co., Ltd. | Position 177,291 shares | Ratio 0.71% | ▲0.33% | — |
| 2026-02-25 | Nomura Securities Co., Ltd. | Position 96,991 shares | Ratio 0.38% | ▼0.30% | Below 0.5% |
| 2026-02-24 | Nomura Securities Co., Ltd. | Position 170,091 shares | Ratio 0.68% | ▲0.20% | — |
| 2026-02-18 | Nomura Securities Co., Ltd. | Position 115,191 shares | Ratio 0.46% | ▼0.14% | Below 0.5% |
| 2026-02-17 | Nomura Securities Co., Ltd. | Position 149,791 shares | Ratio 0.60% | ▲0.44% | — |
| 2026-02-13 | Nomura Securities Co., Ltd. | Position 88,391 shares | Ratio 0.35% | ▼0.20% | Below 0.5% |
| 2026-02-12 | Nomura Securities Co., Ltd. | Position 137,491 shares | Ratio 0.55% | ▲0.27% | — |
Shorted Stocks in the Same Industry Pharmaceutical
| Stock | Estimated ratio | Short sellers |
|---|---|---|
| GNI Group Ltd.2160 | 11.16% | 7 firms |
| Oncolys BioPharma Inc.4588 | 10.35% | 7 firms |
| HEALIOS K.K.4593 | 10.20% | 5 firms |
| SymBio Pharmaceuticals Limited4582 | 9.46% | 7 firms |
| Nxera Pharma Co.,Ltd.4565 | 7.35% | 5 firms |
Related Stocks Same TSE 33 sector
| Stock | Market | TSE 33 Sector | TOPIX-17 Sector | Index |
|---|---|---|---|---|
| KISSEI PHARMACEUTICAL CO.,LTD.4547 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Small 1 |
| SEIKAGAKU CORPORATION4548 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Small 2 |
| EIKEN CHEMICAL CO.,LTD.4549 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Small 1 |
| JCR Pharmaceuticals Co.,Ltd.4552 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Small 1 |
| TOWA PHARMACEUTICAL CO.,LTD.4553 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Small 1 |
| CHUKYO IYAKUHIN CO.,LTD.4558 | Standard Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| ZERIA PHARMACEUTICAL CO.,LTD.4559 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Small 1 |
| AnGes,Inc.4563 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| OncoTherapy Science,Inc.4564 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Nxera Pharma Co.,Ltd.4565 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Small 1 |